Boehringer To Acquire Trutino Under Aggressive Cancer R&D Strategy

Remains Mum On Numbers

Boehringer's Recent Deals Have Focused On Precision Cancer Medicines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business